Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2914 (LINC02914) encodes a long non-coding RNA molecule that is localized in the cytoplasm, motile cilium, and nucleus. It is predicted to play a role in flagellum biology, but its specific biological functions and molecular mechanisms remain largely uncharacterized. LINC02914 is primarily classified as a long non-coding RNA, and the gene is associated with Bardet-Biedl syndrome 12, although its involvement as a direct causative factor has not been elucidated. There are currently no known drugs, mechanisms of drug action, biomarker utility, or safety concerns specific to this lncRNA[3]. No evidence is available in reviewed molecular databases, including GeneCards and UniProtKB, to suggest LINC02914 is a therapeutic target in the sense of being a receptor, enzyme, transporter, or a target of approved drugs[3]. If more detailed functional study or disease association becomes available in the future, entries for biological functions and disease roles should be updated accordingly.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2914 (LINC02914).